Creutzfeldt-Jakob disease historical perspective: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| (10 intermediate revisions by 5 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Creutzfeldt-Jakob disease}} | {{Creutzfeldt-Jakob disease}} | ||
{{CMG}} | {{CMG}} {{AE}}{{MMJ}} | ||
==Overview== | |||
Creutzfeldt Jakob disease was first described in 1920-1921 by two German [[neurologists]], Hans Gerhard Creutzfeldt and Alfons Maria Jakob. Creutzfeldt Jakob disease was first described in 1920-1921 by two German [[neurologist]]s, [[Hans Gerhard Creutzfeldt]] and [[Alfons Maria Jakob]]. The term ''Creutzfeldt Jakob'' was first coined by Spielmeyer in 1922 in honor of Creutzfeldt and Jakob's report. In 1997, [[Stanley B. Prusiner]] was awarded the Nobel Prize in [[physiology]] or medicine for his discovery of [[prion]]s. In 2007, Laura Manuelidis, an American [[neuropathologist]], and her colleagues described a [[virus]]-like particle without [[nucleic acid]] in less than 10% of the cells a [[scrapie]]-infected cell line and in a mouse cell line infected by a human Creutzfeldt Jakob disease agent. | |||
==Historical Perspective== | ==Historical Perspective== | ||
*Creutzfeldt Jakob disease was first described in 1920-1921 by two German [[neurologist]]s, [[Hans Gerhard Creutzfeldt]] and [[Alfons Maria Jakob]]. | |||
*The term ''Creutzfeldt Jakob'' was first coined by Spielmeyer in 1922 in honor of Creutzfeldt and Jakob's report.<ref name="McKintosh-2003">{{Cite journal | last1 = McKintosh | first1 = E. | last2 = Tabrizi | first2 = SJ. | last3 = Collinge | first3 = J. | title = Prion diseases. | journal = J Neurovirol | volume = 9 | issue = 2 | pages = 183-93 | month = Apr | year = 2003 | doi = 10.1080/13550280390194082 | PMID = 12707849 }}</ref> | |||
* In 1997, [[Stanley B. Prusiner]] was awarded the Nobel Prize in physiology or medicine for his discovery of [[prion]]s. | |||
*In 2007, Laura Manuelidis, an American [[Neuropathologist|neuropathologis]]<nowiki/>t, and her colleagues described a [[virus]]-like particle without [[nucleic acid]] in less than 10% of the cells a [[scrapie]]-infected cell line and in a mouse cell line infected by a human Creutzfeldt Jakob disease agent.<ref name="Manuelidis2007">{{cite journal| author=Manuelidis L| coauthors=Yu ZX, Barquero N, Mullins B|date=February 6, 2007| title=Cells infected with scrapie and Creutzfeldt-Jakob disease agents produce intracellular 25-nm virus-like particles| journal=Proceedings of the National Academy of Science| volume=104| issue=6| pages=1975-1970| pmid=17267596|url=http://www.pnas.org/cgi/content/full/104/6/1965| accessdate=2007-09-24}}</ref> | |||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
| Line 13: | Line 17: | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} | ||
[[Category:Neurology]] | [[Category:Neurology]] | ||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category:Transmissible spongiform encephalopathies]] | [[Category:Transmissible spongiform encephalopathies]] | ||
Latest revision as of 16:13, 19 October 2018
|
Creutzfeldt-Jakob disease Microchapters |
|
Differentiating Creutzfeldt-Jakob disease from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Creutzfeldt-Jakob disease historical perspective On the Web |
|
American Roentgen Ray Society Images of Creutzfeldt-Jakob disease historical perspective |
|
Creutzfeldt-Jakob disease historical perspective in the news |
|
Risk calculators and risk factors for Creutzfeldt-Jakob disease historical perspective |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Mohamadmostafa Jahansouz M.D.[2]
Overview
Creutzfeldt Jakob disease was first described in 1920-1921 by two German neurologists, Hans Gerhard Creutzfeldt and Alfons Maria Jakob. Creutzfeldt Jakob disease was first described in 1920-1921 by two German neurologists, Hans Gerhard Creutzfeldt and Alfons Maria Jakob. The term Creutzfeldt Jakob was first coined by Spielmeyer in 1922 in honor of Creutzfeldt and Jakob's report. In 1997, Stanley B. Prusiner was awarded the Nobel Prize in physiology or medicine for his discovery of prions. In 2007, Laura Manuelidis, an American neuropathologist, and her colleagues described a virus-like particle without nucleic acid in less than 10% of the cells a scrapie-infected cell line and in a mouse cell line infected by a human Creutzfeldt Jakob disease agent.
Historical Perspective
- Creutzfeldt Jakob disease was first described in 1920-1921 by two German neurologists, Hans Gerhard Creutzfeldt and Alfons Maria Jakob.
- The term Creutzfeldt Jakob was first coined by Spielmeyer in 1922 in honor of Creutzfeldt and Jakob's report.[1]
- In 1997, Stanley B. Prusiner was awarded the Nobel Prize in physiology or medicine for his discovery of prions.
- In 2007, Laura Manuelidis, an American neuropathologist, and her colleagues described a virus-like particle without nucleic acid in less than 10% of the cells a scrapie-infected cell line and in a mouse cell line infected by a human Creutzfeldt Jakob disease agent.[2]
References
- ↑ McKintosh, E.; Tabrizi, SJ.; Collinge, J. (2003). "Prion diseases". J Neurovirol. 9 (2): 183–93. doi:10.1080/13550280390194082. PMID 12707849. Unknown parameter
|month=ignored (help) - ↑ Manuelidis L (February 6, 2007). "Cells infected with scrapie and Creutzfeldt-Jakob disease agents produce intracellular 25-nm virus-like particles". Proceedings of the National Academy of Science. 104 (6): 1975–1970. PMID 17267596. Retrieved 2007-09-24. Unknown parameter
|coauthors=ignored (help)